| Entry |
|
|---|
| Name |
Triflusal (INN) |
|---|
| Formula |
C10H7F3O4
|
|---|
| Exact mass |
248.0296
|
|---|
| Mol weight |
248.1554
|
|---|
| Structure |
|
|---|
| Class |
Blood modifier agent
DG01950 Antithrombotic agent
DG01712 Antiplatelet agent
|
|---|
| Remark |
|
|---|
| Efficacy |
Platelet aggregation inhibitor, COX-1 inhibitor |
|---|
| Comment |
Salicylic acid derivative
|
|---|
| Target |
|
|---|
| Pathway |
|
|---|
| Interaction |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
B BLOOD AND BLOOD FORMING ORGANS
B01 ANTITHROMBOTIC AGENTS
B01A ANTITHROMBOTIC AGENTS
B01AC Platelet aggregation inhibitors excl. heparin
B01AC18 Triflusal
D07142 Triflusal (INN)
Drug groups [BR:br08330]
Blood modifier agent
DG01950 Antithrombotic agent
DG01712 Antiplatelet agent
D07142 Triflusal
Target-based classification of drugs [BR:br08310]
Enzymes
Oxidoreductases (EC1)
Prostaglandin synthase
PTGS1 (COX1)
D07142 Triflusal (INN)
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
| KCF data |
ATOM 17
1 C8x C 21.1230 -16.8540
2 C8x C 21.1230 -18.2525
3 C8y C 22.3342 -18.9518
4 C8x C 23.5454 -18.2525
5 C8y C 23.5454 -16.8540
6 C8y C 22.3342 -16.1547
7 O7a O 24.7817 -16.1547
8 C7a C 25.9929 -16.8540
9 O6a O 27.2228 -16.1437
10 C1a C 25.9930 -18.2523
11 C6a C 22.3231 -14.7561
12 O6a O 21.1175 -14.0471
13 O6a O 23.5259 -14.0617
14 C1d C 22.3342 -20.3502
15 X F 22.2951 -21.7391
16 X F 20.9342 -20.3502
17 X F 23.7342 -20.3502
BOND 17
1 1 2 2
2 2 3 1
3 3 4 2
4 4 5 1
5 5 6 2
6 1 6 1
7 5 7 1
8 7 8 1
9 8 9 2
10 8 10 1
11 6 11 1
12 11 12 1
13 11 13 2
14 3 14 1
15 14 15 1
16 14 16 1
17 14 17 1
|
|---|
